MedTrace Logo

Locally Delivered 1% Metformin Gel in the Treatment of Intrabony Defects in Chronic Periodontitis

NCT02048761 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2014-03-03

No results posted yet for this study

Summary

This study was designed as a randomized, controlled clinical trial to evaluate the efficacy of 1% MF gel as local drug delivery in adjunct to SRP for the treatment of intrabony defects in chronic periodontitis in comparison with placebo gel.

Conditions

  • Intrabony Defects in Chronic Periodontitis

Interventions

DRUG

Placebo gel

After debridement, a single dose of the placebo gel was applied into the periodontal pockets with a syringe and a blunt canula

DRUG

1 % Metformin gel

After debridement, 1% Metformin gel gel was applied into the periodontal pockets with a syringe and a blunt canula.

Sponsors & Collaborators

  • Government Dental College and Research Institute, Bangalore

    lead OTHER

Principal Investigators

  • A R Pradeep, M.D.S. · Govt Dental College & Research Inst, Bangalore.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02048761 on ClinicalTrials.gov